LENZ Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
LENZ Therapeutics has 1 disclosed supplier and 4 disclosed customers in SEC filings.
SentenceIn January 2026, we deployed a cost-effective, highly targeted and digitally-focused consumer strategy designed to efficiently target the early adopters among the estimated 128 million presbyopes in the U.S, known as the "Make it VIZZable" campaign, with award-winning actor, producer and publisher, Sarah Jessica Parker ("SJP") as a brand ambassador for VIZZ.
LENZ 10-Kaccession 0001815776-26-000011
SentenceWe also granted CORXEL (i) the right to negotiate in good faith and enter into agreements to purchase Products from us for clinical and commercial uses at cost plus a negotiated percentage and (ii) the right of first negotiation to obtain a regional license from us on other products we might develop outside of the field of presbyopia for commercialization in Greater China.
LENZ 10-Kaccession 0001815776-26-000011
SentenceOn July 7, 2025, we entered into a license and commercialization agreement providing an exclusive license (the "Théa License") to register and commercialize VIZZ for the treatment of presbyopia in Canada.
LENZ 10-Kaccession 0001815776-26-000011
SentenceUnder this agreement, we granted Lotus an exclusive license to certain of the Company's IP to commercialize VIZZ for the treatment of presbyopia in adults in the South Korea and Southeast Asia.
LENZ 10-Kaccession 0001815776-26-000011
SentenceUnder the terms of the Lunatus Distribution Agreement, we received a nonrefundable, non-creditable upfront payment, and are eligible to receive regulatory and commercial milestone payments and a per unit fee for each unit sold to Lunatus for distribution in the Middle East, pending regulatory approval.
LENZ 10-Kaccession 0001815776-26-000011
LENZ Therapeutics, Inc.
3.09
Largest filed tie
—
Expected move
Inputsspot 3.05exp Jan 15ATM strike 2.5ATM straddle 1.30IV 122%